Výsledky vyhledávání

Transcriptomic Analysis of a Diabetic Skin-Humanized Mouse Model Dissects Molecular Pathways Underlying the Delayed Wound Healing Response

Autor: León C, García-García F, Llames S, García-Pérez E, Carretero M, Arriba MDC, Dopazo J, Del Río M, Escámez MJ, Martínez-Santamaría L

Publikováno v: Genes
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)

Defective healing leading to cutaneous ulcer formation is one of the most feared complications of diabetes due to its consequences on patients' quality of life and on the healthcare system. A more in-depth analysis of the underlying molecular pathoph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::55b0b4a027636a7e71e332e336bebb34
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3623

Zobrazit plný text záznamu

Akademický článek

FPR2 DNA Aptamers for Targeted Therapy of Wound Repair.

Autor: de Arriba MDC; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Fernández G; Aptus Biotech SL, Madrid, Spain., Chacón-Solano E; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Mataix M; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Martínez-Santamaría L; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Illera N; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Carrión-Marchante R; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Martín ME; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Larcher F; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., González VM; Aptus Biotech SL, Madrid, Spain; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Del Río M; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Carretero M; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain. Electronic address: marta.carretero@ciemat.es.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2022 Aug; Vol. 142 (8), pp. 2238-2248.e8. Date of Electronic Publication: 2022 Jan 01.

Zobrazit plný text záznamu

Akademický článek

Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants.

Autor: Martínez-Santamaría L; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Maseda R; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., de Arriba MDC; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Membrilla JA; Departamento de Neurología, Hospital Universitario La Paz, Madrid, Spain., Sigüenza AI; Servicio de Urgencias, Hospital Universitario La Paz, Madrid, Spain., Mascías J; Departamento de Neurología, Hospital Universitario La Paz, Madrid, Spain., García M; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Quintana L; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Esteban-Rodríguez I; Departamento de Patología, Hospital Universitario La Paz, Madrid, Spain., Hernández-Fernández CP; Departamento de Dermatología, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Illera N; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Duarte B; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Guerrero-Aspizúa S; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Woodley DT; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California., Del Río M, de Lucas R; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Larcher F; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Escámez MJ; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2022 Apr 01; Vol. 158 (4), pp. 439-443.

Zobrazit plný text záznamu

Report

Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.

Autor: Maseda R; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Martínez-Santamaría L; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Sacedón R; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Butta N; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., de Arriba MDC; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., García-Barcenilla S; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., García M; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Illera N; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Pérez-Conde I; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Carretero M; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Jiménez E; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Melen G; Cell & Gene Therapies Laboratory, Niño Jesus University Hospital, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, School of Medicine, La Paz University Hospital, IdiPAZ, Autonomous University of Madrid, Madrid, Spain., Jiménez-Yuste V; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., Vicente Á; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Del Río M; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., de Lucas R; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Escámez MJ; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2020 Nov 26; Vol. 7, pp. 576558. Date of Electronic Publication: 2020 Nov 26 (Print Publication: 2020).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání